Dateline: CAMBRIDGE, Mass., November 19, 2024 – Moderna (MRNA.O) will invest over 140 million to complete its domestic mRNA manufacturing network, enabling full end-to-end production in the United States 1. The expansion strengthens the company’s supply chain independence and reduces reliance...